-
1
Prostate cancer is among the most common cancers in men, with 1.5 million new cases and 397,000 deaths reported globally in 2022.
-
2
AI technologies enhance the diagnosis and treatment of prostate cancer by integrating imaging, pathological, and clinical data for improved accuracy.
-
3
AI models have shown clinical value in detecting, staging, and grading prostate cancer, but most remain unused in practical clinical settings.
-
4
AI assists in surgical procedures, radiation therapy, and drug development, optimizing treatment plans and identifying biomarkers.
-
5
The review aims to summarize AI applications in prostate cancer and promote its integration into clinical practice for better patient outcomes.